NCT04836481View on ClinicalTrials.gov

A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

October 1, 2023

Conditions
Traumatic Brain Injury
Interventions
OTHER

Serum Sample Collection

Each patient will have 5 serum samples collected for analysis after a minimum six consecutive doses. Patients receiving LEV8 will have sampled collected at hours 0.5, 1, 4, 6, and 8. Patients receiving LEV12 will have sampled collected at hours 0.5, 1, 4, 8, and 12.

Trial Locations (1)

45219

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
collaborator

American College of Clinical Pharmacy

OTHER

lead

University of Cincinnati

OTHER

NCT04836481 - A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury | Biotech Hunter | Biotech Hunter